Erik C. Emerson insider trades
Open-market stock purchases and sales by Erik C. Emerson, Chief Executive Officer at Apimeds Pharmaceuticals US, Inc, from SEC Form 4 filings since Nov 1, 2022.
Recent trades
| Date | Stock | Trade | Value |
|---|---|---|---|
| Oct 15, 2025 | APUS Apimeds Pharmaceuticals US, Inc | Bought (not open market) | — |